Genetic variants and risk of prostate cancer using pathway analysis of a genome-wide association study

Neoplasma

Volumn 63, Issue 4, 2016, Pages 629-634

  Kim, Y S ^a   Kim, Y ^a   Choi, J W ^a   Oh, H E ^a   Lee, J H ^a  

^a Korea University   (South Korea)

Author keywords

Genome wide association study; Pathway based analysis; Prostate cancer

Indexed keywords

DNA POLYMERASE REV1; INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHROMOSOME 2; CHROMOSOME 22; CHROMOSOME 4; CONTROLLED STUDY; DNA BINDING; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION BASED CASE CONTROL STUDY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; PROSTATE TUMOR; SIGNAL TRANSDUCTION;

GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84978402775     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2016_418     Document Type: Article

References (28)

1. SIEGEL RL, MILLER KD, JEMAL A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29. http://dx.doi.org/10.3322/ caac.21254
2. BARBIERI CE, TOMLINS SA. Reprint of: The prostate cancer genome: Perspectives and potential. Urol Oncol 2015; 33: 95-102. http://dx.doi.org/10.1016/i.urolonc.2015.01.002
3. CHEN R, REN S, SUN Y. Genome-wide association studies on prostate cancer: the end or the beginning? Protein Cell 2013; 4: 677-686. http://dx.doi.org/10.1007/s13238-013-3055-4
4. HARDY J, SINGLETON A. Genomewide association studies and human disease. N Engl J Med 2009; 360: 1759-1768. http://dx.doi.org/10.1056/NEJMra0808700
5. STRANGER BE, STAHL EA, RAJ T. Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 2011; 187: 367-383. http://dx.doi. org/10.1534/genetics.110.120907
6. RAMANAN VK, SHEN L, MOORE JH, SAYKIN AJ. Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet 2012; 28: 323-332. http:// dx.doi.org/10.1016/i.tig.2012.03.004
7. ELBERS CC, VAN EIJK KR, FRANKE L, MULDER F, VAN DER SCHOUW YT et al. Using genome-wide pathway analysis to unravel the etiology of complex diseases. Genet Epidemiol 2009; 33: 419-431. http://dx.doi.org/10.1002/ gepi.20395
8. ZHANG K, CHANG S, CUI S, GUO L, ZHANG L et al. ICS-NPathway: identify candidate causal SNPs and pathways from genome-wide association study by one analytical framework. Nucleic Acids Res 2011; 39 (Web Server issue): W437-443.
9. YEAGER M, ORR N, HAYES RB, JACOBS KB, KRAFT P et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649. http://dx.doi.org/10.1038/ng2022
10. LEE JH, KIM Y, CHOI JW, KIM YS. Genetic variants and risk of gastric cancer: a pathway analysis of a genome-wide association study. Springerplus 2015; 4: 215. http://dx.doi. org/10.1186/s40064-015-1005-8
11. KANEHISA M, GOTO S, FURUMICHI M, TANABE M, HIRAKAWA M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010; 38 (Database issue): D355-360. http://dx.doi. org/10.1093/nar/gkp896
12. ASHBURNER M, BALL CA, BLAKE JA, BOTSTEIN D, BUTLER H et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29. http://dx.doi.org/10.1038/75556
13. LIU M, DOUBLIE S, WALLACE SS. Neil3, the final frontier for the DNA glycosylases that recognize oxidative damage. Mutat Res 2013; 743-744: 4-11. http://dx.doi.org/10.1016/i. mrfmmm.2012.12.003
14. KAUFFMANN A, ROSSELLI F, LAZAR V, WINNEPEN-NINCKX V, MANSUET-LUPO A et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 2008; 27: 565-573. http:// dx.doi.org/10.1038/si.onc.1210700
15. ZHANG H, MA H, WANG Q, CHEN M, WENG D et al. Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array. Oncol Rep 2010; 23: 445-455.
16. BETHKE L, WEBB E, MURRAY A, SCHOEMAKER M, JOHANSEN C et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 2008; 17: 800-805. http://dx.doi.org/10.1093/hmg/ddm351
17. JIN TB, LI XL, YANG H, JIRI M, SHI XG et al. Association of polymorphisms in FLT3, EGFR, ALOX5, and NEIL3 with glioblastoma in the Han Chinese population. Med Oncol 2013; 30: 718. http://dx.doi.org/10.1007/s12032-013-0718-1
18. BARRY KH, KOUTROS S, BERNDT SI, ANDREOTTI G, HOPPIN JA et al. Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk. Environ Health Perspect 2011; 119: 1726-1732. http://dx.doi. org/10.1289/ehp.1103454
19. HILDRESTRAND GA, NEURAUTER CG, DIEP DB, CASTELLANOS CG, KRAUSS S et al. Expression patterns of Neil3 during embryonic brain development and neoplasia. BMC Neurosci 2009; 10: 45. http://dx.doi.org/10.1186/1471-2202-10-45
20. SHARMA S, HELCHOWSKI CM, CANMAN CE. The roles of DNA polymerase zeta and the Y family DNA polymerases in promoting or preventing genome instability. Mutat Res 2013; 743-744: 97-110. http://dx.doi.org/10.1016/i. mrfmmm.2012.11.002
21. SPITZ MR, AMOS CI, LAND S, WU X, DONG Q et al. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol 2013; 8: 391-397. http://dx.doi. org/10.1097/JTO.0b013e318283da29
22. XU HL, GAO XR, ZHANG W, CHENG JR, TAN YT et al. Effects of polymorphisms in translesion DNA synthesis genes on lung cancer risk and prognosis in Chinese men. Cancer Epidemiol 2013; 37: 917-922. http://dx.doi.org/10.1016/!. canep.2013.08.003
23. SAKIYAMA T, KOHNO T, MIMAKI S, OHTA T, YAN-AGITANI N et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 2005; 114: 730-737. http://dx.doi.org/10.1002/iic.20790
24. HE X, YE F, ZHANG J, CHENG Q, SHEN J et al. REV 1 genetic variants associated with the risk of cervical carcinoma. Eur J Epidemiol 2008; 23: 403-409. http://dx.doi.org/10.1007/ s10654-008-9251-5
25. VARADI V, BEVIER M, GRZYBOWSKA E, JOHANSSON R, ENQUIST K et al. Genetic variation in genes encoding for polymerase zeta subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat 2011; 129: 235-245. http://dx.doi.org/10.1007/s10549-011-1460-z
26. JIA P, WANG L, MELTZER HY, ZHAO Z. Pathway-based analysis of GWAS datasets: effective but caution required. Int J Neuropsychopharmacol 2011; 14: 567-572. http://dx.doi. org/10.1017/S1461145710001446
27. GE YZ, XU Z, XU LW, YU P, ZHAO Y et al. Pathway analysis of genome-wide association study on serum prostate-specific antigen levels. Gene 2014; 551: 86-91. http://dx.doi. org/10.1016/i.gene.2014.08.044
28. LAMBERT JC, GRENIER-BOLEY B, CHOURAKI V, HEATH S, ZELENIKA D et al. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. J Alzheimers Dis 2010; 20: 1107-1118.